These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12519369

  • 1. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans.
    Park KW, Choi JH, Kim HK, Oh S, Chae IH, Kim HS, Oh BH, Lee MM, Park YB, Choi YS.
    Clin Genet; 2003 Jan; 63(1):31-8. PubMed ID: 12519369
    [Abstract] [Full Text] [Related]

  • 2. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 3. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H, Isbir T, Agachan B, Karaali ZE.
    Cell Biochem Funct; 2005 Dec; 23(1):23-8. PubMed ID: 15386541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, van Tol A, Sluiter WJ, Stulp BK.
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [Abstract] [Full Text] [Related]

  • 6. Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis.
    Arca M, Montali A, Ombres D, Battiloro E, Campagna F, Ricci G, Verna R.
    Clin Genet; 2001 Nov; 60(5):374-80. PubMed ID: 11903340
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Nov; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 12. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D, İlhan N, İlhan N, Akbulut M.
    Bosn J Basic Med Sci; 2015 Feb 01; 15(1):9-13. PubMed ID: 25725138
    [Abstract] [Full Text] [Related]

  • 13. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study.
    Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ.
    Arterioscler Thromb Vasc Biol; 2000 May 01; 20(5):1323-9. PubMed ID: 10807749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA, Botma GJ, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Sijbrands EJ, Boer JM, Seidell JC, Jukema JW, Kastelein JJ, Jansen H, Verhoeven AJ, REGRESS Study Group.
    Atherosclerosis; 2008 Sep 01; 200(1):161-7. PubMed ID: 18164013
    [Abstract] [Full Text] [Related]

  • 16. Association of cholesteryl ester transfer protein activity and TaqIB polymorphism with lipoprotein variations in Japanese subjects.
    Ikewaki K, Mabuchi H, Teramoto T, Yamada N, Oikawa S, Sasaki J, Takata K, Saito Y, Japan CETP Study Group.
    Metabolism; 2003 Dec 01; 52(12):1564-70. PubMed ID: 14669156
    [Abstract] [Full Text] [Related]

  • 17. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
    Weitgasser R, Galvan G, Malaimare L, Derflinger I, Hedegger M, Lang J, Iglseder B, Ladurner G, Paulweber B.
    Biomed Pharmacother; 2004 Dec 01; 58(10):619-27. PubMed ID: 15589073
    [Abstract] [Full Text] [Related]

  • 18. Interaction between a common variant of the cholesteryl ester transfer protein gene and the apolipoprotein E polymorphism: effects on plasma lipids and lipoproteins in a cohort of 7-year-old children.
    Rump P, Mensink RP, Hornstra G.
    Nutr Metab Cardiovasc Dis; 2002 Dec 01; 12(6):317-24. PubMed ID: 12669678
    [Abstract] [Full Text] [Related]

  • 19. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
    Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ.
    N Engl J Med; 1998 Jan 08; 338(2):86-93. PubMed ID: 9420339
    [Abstract] [Full Text] [Related]

  • 20. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.
    Cell Biochem Funct; 2009 Oct 08; 27(7):452-7. PubMed ID: 19784962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.